<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>CURE articles</title><description>CURE articles</description><link>https://www.curetoday.com/news</link><category>CURE articles</category><copyright>© 2026 MJH Life Sciences™ and CURE. All rights reserved.</copyright><lastBuildDate>Fri, 19 Jun 2026 21:36:06 +0000</lastBuildDate><ttl>5</ttl><atom:link href="https://www.curetoday.com/rss.xml" rel="self" type="application/rss+xml"/><language>en-us</language><image><title>CURE articles</title><width>144</width><height>47</height><link>https://www.curetoday.com/news</link><url>https://www.curetoday.com/logo.webp</url></image><item><title>&lt;![CDATA[Every Holiday, A Milestone: My Sister&apos;s 11-Year Cancer Journey]]&gt;</title><link>https://www.curetoday.com/view/counting-tomorrow---the-hope-and-weight-of-time-in-cancer</link><guid isPermaLink="true">https://www.curetoday.com/view/counting-tomorrow---the-hope-and-weight-of-time-in-cancer</guid><description>&lt;![CDATA[“For nearly 11 years, my sister measured her cancer fight in holidays—wondering if she&apos;d see spring again, or one more Christmas.”]]&gt;</description><pubDate>Fri, 19 Jun 2026 21:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Oncology Nurse Tammy Zinn on Hope, Heart and 30 Years of Care]]&gt;</title><link>https://www.curetoday.com/view/oncology-nurse-tammy-zinn-on-hope-heart-and-30-years-of-care</link><guid isPermaLink="true">https://www.curetoday.com/view/oncology-nurse-tammy-zinn-on-hope-heart-and-30-years-of-care</guid><description>&lt;![CDATA[Tammy Zinn, a finalist for the Extraordinary Healer Award, reflects on the personal loss that led her to oncology nursing and the programs she built to support patients. ]]&gt;</description><pubDate>Fri, 19 Jun 2026 19:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Oncology Nurse Jill Winther on 3 Decades of Advocacy and Care]]&gt;</title><link>https://www.curetoday.com/view/oncology-nurse-jill-winther-on-3-decades-of-advocacy-and-care</link><guid isPermaLink="true">https://www.curetoday.com/view/oncology-nurse-jill-winther-on-3-decades-of-advocacy-and-care</guid><description>&lt;![CDATA[In a Q&amp;amp;A with CURE, oncology nurse Jill Winther reflects on advocacy, holistic care, and what&apos;s kept her in the field for 35 years. ]]&gt;</description><pubDate>Fri, 19 Jun 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Scanxiety and Long-term Monitoring Strategies]]&gt;</title><link>https://www.curetoday.com/view/scanxiety-and-long-term-monitoring-strategies</link><guid isPermaLink="true">https://www.curetoday.com/view/scanxiety-and-long-term-monitoring-strategies</guid><description>&lt;![CDATA[The discussion addresses practical aspects of living with ALK-positive disease, emphasizing that long-term oral therapy has transformed treatment possibilities from months to potentially decades of survival. ]]&gt;</description><pubDate>Fri, 19 Jun 2026 12:05:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Daily Life Management and Side Effect Monitoring in Patients with ALK-Positive NSCLC]]&gt;</title><link>https://www.curetoday.com/view/daily-life-management-and-side-effect-monitoring-in-patients-with-alk-positive-nsclc</link><guid isPermaLink="true">https://www.curetoday.com/view/daily-life-management-and-side-effect-monitoring-in-patients-with-alk-positive-nsclc</guid><description>&lt;![CDATA[The discussion addresses practical aspects of living with ALK-positive disease, emphasizing that long-term oral therapy has transformed treatment possibilities from months to potentially decades of survival. ]]&gt;</description><pubDate>Fri, 19 Jun 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Tammy Zinn on Replacing Fear With Hope in Oncology Nursing]]&gt;</title><link>https://www.curetoday.com/view/tammy-zinn-on-replacing-fear-with-hope-in-oncology-nursing</link><guid isPermaLink="true">https://www.curetoday.com/view/tammy-zinn-on-replacing-fear-with-hope-in-oncology-nursing</guid><description>&lt;![CDATA[Oncology nurse Tammy Zinn, an Extraordinary Healer finalist, discusses hope, advocacy, and launching Emma&apos;s Wish for patients with cancer. ]]&gt;</description><pubDate>Thu, 18 Jun 2026 19:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[35 Years In, Oncology Nurse Reflects on Advocacy and the &quot;Why&quot;]]&gt;</title><link>https://www.curetoday.com/view/35-years-in-oncology-nurse-reflects-on-advocacy-and-the-why-</link><guid isPermaLink="true">https://www.curetoday.com/view/35-years-in-oncology-nurse-reflects-on-advocacy-and-the-why-</guid><description>&lt;![CDATA[Oncology nurse Jill Winther discusses why understanding treatment reasoning and advocating for patients matters most in cancer care. ]]&gt;</description><pubDate>Thu, 18 Jun 2026 17:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[The Tattoo That Carried Me Through Cancer ]]&gt;</title><link>https://www.curetoday.com/view/the-tattoo-that-carried-me-through-cancer</link><guid isPermaLink="true">https://www.curetoday.com/view/the-tattoo-that-carried-me-through-cancer</guid><description>&lt;![CDATA[A breast cancer survivor recalls how her phoenix tattoo, chosen years before diagnosis, became a lasting symbol of resilience, survival, and hope.]]&gt;</description><pubDate>Thu, 18 Jun 2026 14:51:34 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[10 Things That Got Me Through Treatment ft. Kiana Wooten]]&gt;</title><link>https://www.curetoday.com/view/10-things-that-got-me-through-treatment-ft-kiana-wooten</link><guid isPermaLink="true">https://www.curetoday.com/view/10-things-that-got-me-through-treatment-ft-kiana-wooten</guid><description>&lt;![CDATA[10 Things That Got Me Through Treatment ft. Kiana Wooten]]&gt;</description><pubDate>Wed, 17 Jun 2026 20:55:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Why I Don&apos;t Say &apos;Cancer-Free&apos;: Superstition, N.E.D. and the Evil Eye]]&gt;</title><link>https://www.curetoday.com/view/-why-i-don-t-say-cancer-free-superstition-n-e-d-and-the-evil-eye-</link><guid isPermaLink="true">https://www.curetoday.com/view/-why-i-don-t-say-cancer-free-superstition-n-e-d-and-the-evil-eye-</guid><description>&lt;![CDATA[A breast cancer survivor explains why she avoids saying &apos;cancer-free,&apos; choosing N.E.D. and superstition instead to protect her hard-won health.&quot;]]&gt;</description><pubDate>Wed, 17 Jun 2026 17:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Hair Loss, Fertility and Long-Term Health: What Parents of Kids With Cancer Need to Know]]&gt;</title><link>https://www.curetoday.com/view/hair-loss-fertility-and-long-term-health-what-parents-of-kids-with-cancer-need-to-know</link><guid isPermaLink="true">https://www.curetoday.com/view/hair-loss-fertility-and-long-term-health-what-parents-of-kids-with-cancer-need-to-know</guid><description>&lt;![CDATA[A pediatric oncologist explains how scalp cooling, fertility preservation and early planning protect children with cancer well beyond treatment.]]&gt;</description><pubDate>Wed, 17 Jun 2026 15:19:34 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Living with Metastatic Cancer Means Loss in the Midst of Love ]]&gt;</title><link>https://www.curetoday.com/view/living-with-metastatic-cancer-means-loss-in-the-midst-of-love</link><guid isPermaLink="true">https://www.curetoday.com/view/living-with-metastatic-cancer-means-loss-in-the-midst-of-love</guid><description>&lt;![CDATA[&quot;Losing friends to metastatic breast cancer brings cumulative grief. Self-care, community, and honoring memories can help you cope with repeated loss.&quot; -Martha Carlson]]&gt;</description><pubDate>Tue, 16 Jun 2026 21:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[More Than Medicine: The Power of Trust Between Patient and Doctor]]&gt;</title><link>https://www.curetoday.com/view/more-than-medicine-the-power-of-trust-between-patient-and-doctor</link><guid isPermaLink="true">https://www.curetoday.com/view/more-than-medicine-the-power-of-trust-between-patient-and-doctor</guid><description>&lt;![CDATA[A kidney cancer survivor reflects on National Doctors Day and how trust with his oncologist, Dr. Toni Choueiri, became a lifelong bond.]]&gt;</description><pubDate>Tue, 16 Jun 2026 18:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[ZUSDURI and the ENVISION Trial: A Non-Surgical Path Forward for Recurrent Bladder Cancer]]&gt;</title><link>https://www.curetoday.com/view/zusduri-and-the-envision-trial-a-non-surgical-path-forward-for-recurrent-bladder-cancer</link><guid isPermaLink="true">https://www.curetoday.com/view/zusduri-and-the-envision-trial-a-non-surgical-path-forward-for-recurrent-bladder-cancer</guid><description>&lt;![CDATA[ZUSDURI&apos;s ENVISION trial shows a non-surgical, office-based option that reduces bladder cancer recurrence and improves patient quality of life.]]&gt;</description><pubDate>Tue, 16 Jun 2026 16:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Breast Cancer Survivor Uses Her Journey to Advocate for Hispanic Patients]]&gt;</title><link>https://www.curetoday.com/view/breast-cancer-survivor-uses-her-journey-to-advocate-for-hispanic-patients</link><guid isPermaLink="true">https://www.curetoday.com/view/breast-cancer-survivor-uses-her-journey-to-advocate-for-hispanic-patients</guid><description>&lt;![CDATA[After surviving breast cancer and relapsed non-Hodgkin lymphoma, Maitte Penalver is helping Hispanic patients with cancer feel seen, heard and supported through advocacy and education.]]&gt;</description><pubDate>Tue, 16 Jun 2026 13:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[&quot;You Think It Won&apos;t Happen to You&quot; — Teddi Mellencamp on Melanoma and Speaking Up]]&gt;</title><link>https://www.curetoday.com/view/you-think-it-won-t-happen-to-you-teddi-mellencamp-on-melanoma-and-speaking-up</link><guid isPermaLink="true">https://www.curetoday.com/view/you-think-it-won-t-happen-to-you-teddi-mellencamp-on-melanoma-and-speaking-up</guid><description>&lt;![CDATA[The former Real Housewives star opens up about her melanoma journey, the nurses who kept her sane, and why vulnerability might be the most powerful health tool there is.]]&gt;</description><pubDate>Mon, 15 Jun 2026 21:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Bridging the Gap for Latina Breast Cancer Survivors]]&gt;</title><link>https://www.curetoday.com/view/bridging-the-gap-for-latina-breast-cancer-survivors</link><guid isPermaLink="true">https://www.curetoday.com/view/bridging-the-gap-for-latina-breast-cancer-survivors</guid><description>&lt;![CDATA[Survivorship coach Eileen Lopez Tomei discusses the unique cultural barriers Hispanic and Latina cancer survivors face and why bilingual community events matter.]]&gt;</description><pubDate>Mon, 15 Jun 2026 14:39:24 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Reclaim Your Strength: Simple At-Home Exercise for Cancer Patients &amp; Survivors]]&gt;</title><link>https://www.curetoday.com/view/reclaim-your-strength-simple-at-home-exercises-for-cancer-patients-survivors</link><guid isPermaLink="true">https://www.curetoday.com/view/reclaim-your-strength-simple-at-home-exercises-for-cancer-patients-survivors</guid><description>&lt;![CDATA[Oncology PT Dr. Leslie Waltke shares a simple at-home exercise to help cancer patients and survivors rebuild strength, balance, and mobility]]&gt;</description><pubDate>Sat, 13 Jun 2026 19:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Stage 4 Colon Cancer Survivor Turns Misdiagnosis Into Advocacy]]&gt;</title><link>https://www.curetoday.com/view/stage-4-colon-cancer-survivor-turns-misdiagnosis-into-advocacy</link><guid isPermaLink="true">https://www.curetoday.com/view/stage-4-colon-cancer-survivor-turns-misdiagnosis-into-advocacy</guid><description>&lt;![CDATA[After a stage 4 colon cancer diagnosis at age 40, survivor Kasia Orzechowska now advocates for early screening and self-advocacy to help save lives.]]&gt;</description><pubDate>Sat, 13 Jun 2026 15:14:08 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Your Tumor&apos;s Genetic Profile May Not Change Which Treatment Works Best for TNBC]]&gt;</title><link>https://www.curetoday.com/view/your-tumor-s-genetic-profile-may-not-change-which-treatment-works-best-for-tnbc</link><guid isPermaLink="true">https://www.curetoday.com/view/your-tumor-s-genetic-profile-may-not-change-which-treatment-works-best-for-tnbc</guid><description>&lt;![CDATA[New ASCO data show a TNBC drug combo works for nearly all patients no matter their tumor&apos;s genetic profile. ]]&gt;</description><pubDate>Fri, 12 Jun 2026 19:30:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[FDA Approves Welireg Plus Keytruda Combination for Adjuvant Treatment of Renal Cell Carcinoma]]&gt;</title><link>https://www.curetoday.com/view/fda-approves-welireg-plus-keytruda-combination-for-adjuvant-treatment-of-renal-cell-carcinoma</link><guid isPermaLink="true">https://www.curetoday.com/view/fda-approves-welireg-plus-keytruda-combination-for-adjuvant-treatment-of-renal-cell-carcinoma</guid><description>&lt;![CDATA[FDA approves Welireg plus Keytruda for adults with high-risk renal cell carcinoma following nephrectomy based on phase 3 LITESPARK-022 trial results]]&gt;</description><pubDate>Fri, 12 Jun 2026 17:04:44 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[A CAR-T Therapy Is Working Better Than Expected for Patients With Hard to Treat Leukemia]]&gt;</title><link>https://www.curetoday.com/view/a-car-t-therapy-is-working-better-than-expected-for-patients-with-hard-to-treat-leukemia</link><guid isPermaLink="true">https://www.curetoday.com/view/a-car-t-therapy-is-working-better-than-expected-for-patients-with-hard-to-treat-leukemia</guid><description>&lt;![CDATA[New data show a leukemia treatment working better in real patients than expected with response rates nearly double what trials showed. Here&apos;s what it could mean for you.]]&gt;</description><pubDate>Fri, 12 Jun 2026 14:43:06 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Shared Decision-Making and Treatment Planning for Patients with ALK-Positive NSCLC]]&gt;</title><link>https://www.curetoday.com/view/shared-decision-making-and-treatment-planning-for-patients-with-alk-positive-nsclc</link><guid isPermaLink="true">https://www.curetoday.com/view/shared-decision-making-and-treatment-planning-for-patients-with-alk-positive-nsclc</guid><description>&lt;![CDATA[Dr. Florez introduces shared decision-making as a collaborative approach ensuring patient voices, values, and goals become integral components of treatment planning, particularly crucial for young patients facing long-term therapy with implications spanning treatment selection, side effect management, and family dynamics.]]&gt;</description><pubDate>Fri, 12 Jun 2026 12:05:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Biomarker Testing and Treatment Selection in ALK-Positive NSCLC]]&gt;</title><link>https://www.curetoday.com/view/biomarker-testing-and-treatment-selection-in-alk-positive-nsclc</link><guid isPermaLink="true">https://www.curetoday.com/view/biomarker-testing-and-treatment-selection-in-alk-positive-nsclc</guid><description>&lt;![CDATA[The discussion transitions to biomarker testing as an essential component of lung cancer diagnosis, with Dr. Florez emphasizing that diagnosis remains incomplete until molecular characterization is performed.]]&gt;</description><pubDate>Fri, 12 Jun 2026 12:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Olympic Legend Shannon Miller Talks 15 Years Cancer-Free and Salto Health Launch ]]&gt;</title><link>https://www.curetoday.com/view/olympic-legend-shannon-miller-talks-15-years-cancer-free-and-salto-health-launch</link><guid isPermaLink="true">https://www.curetoday.com/view/olympic-legend-shannon-miller-talks-15-years-cancer-free-and-salto-health-launch</guid><description>&lt;![CDATA[Olympic gymnast Shannon Miller marks 15 years cancer-free, sharing how her platform Salto Health helps survivors bridge the gap in practical support. ]]&gt;</description><pubDate>Thu, 11 Jun 2026 21:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[From &quot;Not Curable&quot; to &quot;May Be Curable&quot;: Joshua Richter, MD, on the New Reality of Multiple Myeloma]]&gt;</title><link>https://www.curetoday.com/view/from-not-curable-to-may-be-curable-joshua-richter-md-on-the-new-reality-of-multiple-myeloma</link><guid isPermaLink="true">https://www.curetoday.com/view/from-not-curable-to-may-be-curable-joshua-richter-md-on-the-new-reality-of-multiple-myeloma</guid><description>&lt;![CDATA[In this episode of The Moonlight Shift, Joshua Richter, MD, associate professor of medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology, and director of Multiple Myeloma at the Blavatnik Family- Chelsea Medical Center at Mount Sinai, joins host Gina Mauro for a conversation about a disease he says he can no longer describe the way he once did — and why that change is one of the most remarkable shifts in modern oncology.]]&gt;</description><pubDate>Thu, 11 Jun 2026 19:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Why Cancer Survivorship Can Be the Hardest Part, Psychologist Says]]&gt;</title><link>https://www.curetoday.com/view/why-cancer-survivorship-can-be-the-hardest-part-psychologist-says</link><guid isPermaLink="true">https://www.curetoday.com/view/why-cancer-survivorship-can-be-the-hardest-part-psychologist-says</guid><description>&lt;![CDATA[Psychologist Ian Sadler explains why many patients with cancer face anxiety and emotional challenges after treatment ends and why mental health support matters.]]&gt;</description><pubDate>Thu, 11 Jun 2026 15:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Long-Term Data From COMMANDS Trial Show Reblozyl May Help Patients With Lower-Risk MDS Live Longer]]&gt;</title><link>https://www.curetoday.com/view/long-term-data-from-commands-trial-show-reblozyl-may-help-patients-with-lower-risk-mds-live-longer</link><guid isPermaLink="true">https://www.curetoday.com/view/long-term-data-from-commands-trial-show-reblozyl-may-help-patients-with-lower-risk-mds-live-longer</guid><description>&lt;![CDATA[Updated COMMANDS trial data show Reblozyl improved survival and long-term transfusion independence vs. Epogen in lower-risk MDS patients.]]&gt;</description><pubDate>Thu, 11 Jun 2026 14:13:15 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[Experimental Treatment Shrinks Tumors in Aggressive Adenoid Cystic Carcinoma]]&gt;</title><link>https://www.curetoday.com/view/experimental-treatment-shrinks-tumors-in-rare-salivary-gland-cancer</link><guid isPermaLink="true">https://www.curetoday.com/view/experimental-treatment-shrinks-tumors-in-rare-salivary-gland-cancer</guid><description>&lt;![CDATA[Early ASCO data show emiltatug ledadotin produced durable responses in patients with aggressive adenoid cystic carcinoma.]]&gt;</description><pubDate>Wed, 10 Jun 2026 17:00:00 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item><item><title>&lt;![CDATA[5-Year Data Support Personalized Vaccine in High-Risk Melanoma]]&gt;</title><link>https://www.curetoday.com/view/5-year-data-support-personalized-vaccine-in-high-risk-melanoma</link><guid isPermaLink="true">https://www.curetoday.com/view/5-year-data-support-personalized-vaccine-in-high-risk-melanoma</guid><description>&lt;![CDATA[Five-year KEYNOTE-942 data show a personalized cancer vaccine plus Keytruda reduced recurrence risk in patients with high-risk melanoma.]]&gt;</description><pubDate>Wed, 10 Jun 2026 14:10:09 GMT</pubDate><media:credit role="publishing company">CURE</media:credit><category>us</category><source url="https://www.curetoday.com/rss.xml">CURE Articles</source></item></channel></rss>